Lantheus LNTH 深 滬
已收盤 11-06 16:00:00 美东时间
100.61
-0.090
-0.09%
華盛通- 最 高101.02
- 今 開100.73
- 成交量 157.60万股
- 最 低 100.40
- 昨 收 100.70
- 總市值 65.70亿
- 52周最高 111.86
- 市盈率 靜 29.48
- 換手率 2.41%
- 52周最低 51.80
- 委 比 -50.47%
- 總股本 6529.99万
- 歷史最高 126.8899
- 量 比 1.76
- 振 幅 0.62%
- 歷史最低 1.76
- 每 手 1
- 風險率 17.02%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多财报速睇 | Lantheus 2026财年Q3营收3.90亿美元，同比增长1.5%；归母净利润0.22亿美元，同比下滑19.4%
华盛资讯11月5日讯，Lantheus公布2026财年Q3业绩，公司Q3营收3.90亿美元，同比增长1.5%，归母净利润0.22亿美元，同比下滑19.4%。
11-05 21:10
财报速睇 | Lantheus 2026财年Q3营收3.90亿美元，同比增长1.5%；归母净利润0.22亿美元，同比下滑19.4%
华盛资讯11月5日讯，Lantheus公布2026财年Q3业绩，公司Q3营收3.90亿美元，同比增长1.5%，归母净利润0.22亿美元，同比下滑19.4%。
11-05 21:02
Lantheus Holdings Q3 Adj. EPS $1.68 Beats $1.24 Estimate, Sales $389.913M Beat $359.757M Estimate
Lantheus Holdings (NASDAQ:LNTH) reported quarterly earnings of $1.68 per share which beat the analyst consensus estimate of $1.24 by 35.48 percent. This is a 32.28 percent increase over earnings of $1.27 per share from the same period last year. The company reported quarterly sales of $389.913 milli...
11-05 20:57
Lantheus Welcomes CMS CY27 Final Rule Advancing Access to Diagnostic Radiopharmaceuticals
Lantheus Holdings welcomed CMS's final rule maintaining separate payment for advanced diagnostic imaging agents and confirming PYLARIFY TruVu's Transitional Pass-Through status through September 30, 2029. A permanent HCPCS code (A9613) for PYLARIFY TruVu became effective October 1, 2026, aiding billing and reimbursement. Amanda Morgan highlighted the rule's support for patient access to advanced imaging and innovative radiopharmaceuticals, emphas...
11-05 12:15
Lantheus Holdings收跌0.15%，成交额9354.36万美元
11月3日，Lantheus Holdings（LNTH）收跌0.15%，报100.31美元，成交额9354.36万美元，市值65.5亿美元。 行情数据 • 开...
11-03 06:00
Lantheus Announces Presentation of Data at the 2026 Clinical Trials on Alzheimer’s Disease Annual Meeting
Lantheus Holdings, Inc. will present data at the 2026 Clinical Trials on Alzheimer’s Disease (CTAD) Annual Meeting in Boston. The presentations include two posters: one on tau pathology detection using florquinitau F 18 PET and another on astrocytic MAO-B imaging with 18F-FDED PET. The company, a leader in radiopharmaceuticals, aims to improve patient outcomes through innovative imaging solutions.
11-02 13:30
Lantheus Holdings收涨0.12%，成交额4314.55万美元
10月27日，Lantheus Holdings（LNTH）收涨0.12%，报99.92美元，成交额4314.55万美元，市值65.25亿美元。 行情数据 •...
10-27 05:01
Lantheus Merger Review Intensifies After FTC Second Request
Lantheus ( ($LNTH) ) has provided an announcement. On August 3, 2026, Lantheus ...
10-22 19:59
Lantheus Holdings收跌0.29%，成交额1.71亿美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 05:02
Lantheus Shareholders Approve Merger with Curium Holdings
Lantheus ( ($LNTH) ) has issued an announcement. On October 14, 2026, Lantheus ...
10-15 05:01
